Franklin Resources’s Akero Therapeutics AKRO Stock Holding History

Franklin Resources’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-97,251	Closed	-$4.62M	–	3122
2025 Q3	$4.62M	Buy	97,251 +68,678	+240%	+$3.33M	﹤0.01%	1443
2025 Q2	$1.52M	Buy	28,573 +18,176	+175%	+$826K	﹤0.01%	1803
2025 Q1	$421K	Buy	+10,397	New	+$441K	﹤0.01%	2336
2024 Q2	–	Sell	-11,601	Closed	-$293K	–	2866
2024 Q1	$293K	Sell	11,601 -10,198	-47%	-$245K	﹤0.01%	2473
2023 Q4	$509K	Sell	21,799 -1,093	-5%	-$21.6K	﹤0.01%	1931
2023 Q3	$1.16M	Buy	22,892 +4,647	+25%	+$216K	﹤0.01%	1564
2023 Q2	$852K	Buy	+18,245	New	+$836K	﹤0.01%	1704

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Franklin Resources's AKRO Position: Q4 2025 in Review

Franklin Resources sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 97,251 shares — an estimated $4.62M sold.

Franklin Resources first reported a position in AKRO in Q2 2023 and held it in 7 quarters. The position peaked at $4.62M in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Franklin Resources reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Franklin Resources sold 97,251 Akero Therapeutics shares in Q4 2025, an estimated $4.62M.
Franklin Resources first reported a position in Akero Therapeutics in Q2 2023 and held it in 7 quarters.
Franklin Resources's Akero Therapeutics position peaked at $4.62M in Q3 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Franklin Resources's 13F filing for Q4 2025, filed 11 Feb 2026.